Encompass Health (EHC)
Provides intensive inpatient rehabilitation through a nationwide hospital network.
Something off on this page? Send us feedback.
Provides facility-based rehabilitation for patients recovering from major injuries and illnesses through a U.S. hospital network. Revenue comes mainly from reimbursed inpatient care, while standardized clinical protocols and joint-venture expansion define the operating model.
Provides intensive, facility-based rehabilitation for patients recovering from neurological, orthopedic, cardiac, pulmonary and other serious conditions. The focused portfolio consists of inpatient rehabilitation hospitals across the United States and Puerto Rico.
Care combines therapy, frequent physician visits and continuous nursing oversight under standardized clinical protocols. Growth comes through new hospitals, licensed-bed additions, acquisitions and joint ventures with acute-care hospitals and health systems.
Revenue is generated primarily from reimbursed inpatient care. Medicare and Medicare Advantage supply most revenue, alongside managed-care insurers, Medicaid and patients. Operations depend on reimbursement rules, quality standards, referral access, clinical staffing and joint-venture relationships.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 7, 2026 | Truist Financial | Target | Target: $140 | Target: $150 |
| Aug 7, 2026 | UBS | Reiterate | Rating: —Target: $150 | Target: $155 |
| Aug 6, 2026 | Barclays | Reiterate | Rating: —Target: $140 | Target: $144 |
| May 22, 2026 | Leerink Partners | Target | Target: — | Target: $152 |
| May 5, 2026 | Barclays | Reiterate | Rating: —Target: $153 | Target: $140 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $107.7M · Total debt $2.84B · Total assets $7.46B · Shareholders' equity $2.60B
- Revenue
- $1.60B
- Operating income
- $288.4M
- Net income
- $153.9M
HistoryDividendAnnual yieldUpcoming
| Institutions | 97.18% | 96.40M shares | |
|---|---|---|---|
| 613 holders · as of Jun 30, 2026 | |||
| Insiders | 0.88% | 871.8K shares | |
| 17 holders · as of Sep 1, 2026 | |||
| Strategic holders | 8.13% | 8.06M shares | |
| 1 holder · as of Feb 14, 2017 | |||
| Adds to | 106.19% | ||
99.20M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 106.19%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 10.57% | 10.48M | as of Jun 30, 2026 |
Highbridge Capital Management, LLCStrategic | 8.13% | 8.06M | filed Feb 14, 2017 |
Price T Rowe Associates Inc /MD/Institution | 5.10% | 5.06M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 4.96% | 4.92M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 4.51% | 4.48M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 31, 2026 | John Patrick Darby | officer: EVP, Gen Counsel & Secretary | −4,858 | $121.09 |
| Aug 31, 2026 | Andrew L. Price | officer: Chief Accounting Officer | −5,211 | $120.93 |
| Aug 10, 2026 | John Patrick Darby | officer: EVP, Gen Counsel & Secretary | −8,906 | $125.95 |
| Aug 10, 2026 | Mark J. Tarr | director, officer: President & CEO | −173,148 | $125.47 |
| Aug 10, 2026 | Douglas E. Coltharp | officer: EVP & Chief Financial Officer | −18,869 | $125.38 |
- HCA Healthcare
Acute-care rehabilitation network competing for referrals and IRF patients
- Universal Health Services
Acute-care rehabilitation units contesting local IRF referrals
- The Ensign Group
Skilled-nursing substitute for less-intensive post-acute rehabilitation
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Encompass Health | $124.42 | +2.35% | $12.06B | 19.8 | 19.4 | 1.9 | +9.6% |
| HCA Healthcare | $441.01 | +3.53% | $92.22B | 14.3 | 14.4 | 1.2 | +8.7% |
| Universal Health Services | $181.13 | +3.66% | $10.58B | 7.2 | 7.9 | 0.6 | +8.3% |
| The Ensign Group | $176.95 | +1.42% | $10.17B | 27.3 | 21.6 | 1.9 | +17.3% |
| Median | 14.3 | 14.4 | 1.2 | +8.7% |